Hints and tips:
...Romosozumab was discovered by Celltech, the UK biotech company acquired by UCB for £1.5bn in 2004, working with South African scientists investigating how sclerosteosis had been passed down generations of...
...“Dr Harper says anti-cancer company British Biotech ‘wrecked the sector’, but the UK has had successes such as Celltech, bought by UCB for £1.53bn, or Cambridge Antibody Technology and KuDos, bought by AstraZeneca...
...Jeff Alexander, executive director for global competitiveness at the South East England Development Agency, says: “The Thames Valley is home to companies including Bayer, Wyeth and Celltech....
...Celltech was purchased by Belgium’s UCB for £1.53bn ($3.03bn, €1.93bn)....
...Celltech was bought in 2004 by UCB, a Belgian pharmaceutical company, for £1.53bn. The price represented a 28 per cent premium to market valuation....
...The emergence of biotech has led to a number of UK companies being snapped up – Cambridge Antibody Technologies was bought by AstraZeneca, while UCB bought Celltech as far back as 2004 and Eli Lilly purchased...
...He was also the founder of Chiroscience, the genomics company that went on to merge with Celltech in 1999. Celltech was subsequently bought by the Belgian group UCB for £1.5bn in 2004....
...UCB took a similar step towards biotechnology with its €2.25bn purchase two years ago of Celltech of the UK....
...UCB shares which have risen 22.6 per cent since it made its bid for Celltech in May, were up rose 0.4 to 43.04....
International Edition